Join us at the Rosewood Villa Magna in Central Madrid
Sunday, October 25 • Doors open 18:30 CET
A special symposium on the state of MRD detection research in Europe
Join us for an exclusive event exploring how accessible, harmonized whole genome data can accelerate the adoption of minimal residual disease (MRD) detection across Europe. We'll examine the current state of MRD technology and its clinical utility, featuring leading European experts in translational and clinical oncology.
Registration will open at 18:30. Dinner will be served throughout the main program, with a networking drinks and special event following the main program.
Meeting Co-Chairs
Plenary • 19:00 - 19:45 CET
Program Talks
Fireside Chat • 20:00 - 20:45 CET
Fireside Chat: The adoption gap: bringing MRD into European practice
Flamenco Show & Networking • 20:45+ CET
Join us for a unique Madrid experience
Detailed Agenda
| Time | Speaker/Session | Talk Title |
|---|---|---|
| 18:30 | Registration opens | |
| 19:00 - 20:45 | Dinner & refreshments | |
| 19:00 - 19:15 | Dan Landau, PhD | The plasma genome as a sensor |
| 19:15 - 19:30 | Jonathan C. M. Wan, MD, PhD | Error-corrected plasma whole-genome sequencing for minimal residual disease detection in TRACERx |
| 19:30 - 19:45 | Pan-cancer monitoring of tumor response using ultrasensitive ppmSeq | |
| 20:00 - 20:45 | Fireside Chat | The adoption gap: bringing MRD into European practice |
| 20:45+ | Drinks & networking | Flamenco performance |